Arborgen Holdings Limited · NZX:ARB
Arborgen — FY2026 Earnings Presentation
18 slides from Arborgen's earnings presentation, Mar 31, 2026
Slide 1: FY26 Results Presentation
FY26 Results Presentation For the 12 months ended 31 March 2026 All financials in USD unless otherwise stated
Slide 2: Who We Are: A World Leader in Forestry Genetics
WHO WE ARE A WORLD LEADER IN FORESTRY GENETICS ArborGen is a global leader in genetically advanced tree seedlings for commercial forestry. With decades of investment in breeding science and intellectual property, we deliver measurably superior trees to landowners across the US South and Brazil — the
Slide 3: Our Markets
OUR MARKETS US SOUTH BRAZIL • Largest loblolly pine market globally — 700m • World's largest hardwood pulp producer — seedling total market eucalyptus demand est. 1.2 billion seedlings p.a. • Addressable market ~570m seedlings vs current • Addressable market ~720m seedlings; ArborGen ~205m sales — s
Slide 4: Dual Pathway Strategy
DUAL PATHWAY STRATEGY Driving growth and leveraging long-term demand trends GO TO MARKET OPERATING STRENGTH The US South and Brazil Grow demand and sales of Enable a strong foundation for remain our primary markets higher value advanced genetics the future seedlings We are building a strong platform
Slide 5: FY26 Summary
FY26 SUMMARY DELIVERED YEAR-ON-YEAR GROWTH Strategic focus on advanced genetics, added value products and operational improvements driving improved result Uplift in revenue and earnings Continued growth momentum in Brazil Alignment and rightsizing of US business to a lower industry baseline Positive
Slide 6: FY26 Performance Snapshot
FY26 PERFORMANCE SNAPSHOT Highest revenue result in 5 years; Adj US GAAP EBITDA up 31% YOY SALES VOLUME AND REVENUE ADJUSTED US GAAP EBITDA (US $M) (US $M) 12.8 11.5 375m 369m 360m 10.1 328m 324m 9.2 8.8 67.7 68.2 63.2 56.1 47.5 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Sales Revenue Sales V
Slide 7: FY26 Numbers at a Glance
FY26 NUMBERS AT A GLANCE For the year ended 31 March 2026. Percentage comparatives to prior year. All numbers in USD unless stated otherwise. SEEDLING UNIT SALES REVENUE GROSS PROFIT NET LOSS AFTER TAX 323.9m $68.2m $19.8m $(7.5)m1 FY25: 327.8m FY25: $63.2m FY25: $18.2m FY25: $(21.5)m Down 1% Up 8%
Slide 8: FY26: Go to Market
FY26: GO TO MARKET Grow demand and sales of higher value advanced genetics seedlings UNITED STATES BRAZIL MARKET DRIVEN GENETICS FOR THE FUTURE • Structural shift in commercial landscape, • Investing in and expanding portfolio weakening the near and medium term of higher value protected clones Conti
Slide 9: FY26: Operating Strength
FY26: OPERATING STRENGTH Enable a strong foundation for the future Optimising productivity • Continued focus on cost and efficiencies • Rightsizing team and optimising production in US to reflect structural market changes • Successful implementation of new ERP system in US in April 2026 • Continuing
Slide 10: FY26 Financial Summary
FY26 FINANCIAL SUMMARY Strong result in face of US market headwinds; Brazil market continues to deliver US $M FY26 FY25 • Revenue increase driven by improved sales mix Revenue 68.2 63.2 (higher value and added value products) Gross Profit 19.8 18.2 • Continuing focus on efficiencies and cost managem
Slide 11: Seedling Sales and Revenue
SEEDLING SALES AND REVENUE Strong growth in Brazil, US South headwinds continue to put pressure on sales SALES REVENUE US$M • Increase in Average Sales Price (ASP) across 4.5 68.2 63.2 0.5 both businesses • Revenue up 8% YOY vs 1% decrease in volumes • Driven by continued uptake of higher margin pro
Slide 12: US South
US SOUTH Strategic alignment of business to structural industry shift SALES VOLUME AND REVENUE (US $M) • Consistent YOY revenue (up 1%) despite lower volumes, supported by sales of higher value products 284 265 257 • 6% increase in average sales price, driven 214 205 by higher-value sales mix (advan
Slide 13: Brazil
BRAZIL Building blocks in place creating a stronger business; a market in structural growth • Record full year sales volume and revenue Local Currency R$ driven by strong demand for both pine and 113 113 119 eucalyptus; revenue up 14% in local 102 164.0 currency 144.4 78 130.5 • 9% increase in avera
Slide 14: US GAAP EBITDA
US GAAP EBITDA 31% YOY increase in Adjusted US GAAP EBITDA US GAAP EBITDA US $M • Adjusted US GAAP EBITDA of $11.5m, up 12.8 12.5 31% YOY 11.2 11.5 10.1 10.3 • Increasing revenue plus cost discipline and 9.2 8.8 efficiency improvement driving higher 7.6 earnings 6.1 • Continued strength even in the
Slide 15: Balance Sheet Summary
BALANCE SHEET SUMMARY US $m FY26 FY25 • Capital expenditure $4.1m Debtors 12.0 12.8 • Disciplined management of working capital Inventory1 42.0 38.4 • Increase in inventory due to continued investment Creditors (10.0) (12.9) in secure seed supply, volume and business Working Capital 39.3 38.0 growth
Slide 16: Outlook
OUTLOOK ArborGen is entering FY27 with a stronger operational platform, a more resilient business and clear opportunities for growth. The deliberate and disciplined choices being made today will enable the business to perform well in a more subdued US market, while continuing to grow in Brazil. For
Slide 17: Adjusted US GAAP Reconciliation
ADJUSTED US GAAP RECONCILIATION 1. Under US GAAP, from a statutory reporting perspective, the classification of the Fiscal year ending March US $m Mar expense items, and other significant items in this table may differ from what is 2026 presented in the financial statements. US GAAP 2. US GAAP EBITD
Slide 18: Disclaimer
DISCLAIMER This presentation has been prepared by ArborGen Holdings Limited (“ArborGen”), to provide an overview of the performance of ArborGen and its activities at the date of this presentation. It is not prepared for any other purpose and must not be provided to any person other than the intended